]>
IRCT2015101714333N44 IRCT 2015-11-03 Vice chancellor for research, Kermanshah University of Medical Sciences Prophylactic Effects of Levetiracetam on Migraine in 4-14 Years Old Children Effectiveness and ineffectiveness of Prophylactic of Levetiracetam on migraine in 4-14 Years Old Children 2014-01-21 anticipated 30 Complete https://irct.ir/trial/13978 interventional Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment. N/A Migraine. In the experimental group, before starting the study the questionnaire of disability due to headache (PedMIDAS) will be provided, then levetiracetam tablets 20 mg per kg body weight), is prescribed and patients with a phone call and if its necessary by referring, every month follow up for at least 6 months and the questionnaire of disability due to headache (PedMIDAS) every 3 months untill 6 months, will be checked. And the frequency and severity of headaches will be checked in compare with before start of treatment.
public
scientific Dr. Sedighi Mostafa
Mohammad Kermanshahi Hospital, Crossroads of Shirkhorshid
kermanshah Iran (Islamic Republic of) 6715847134 +98 83 3721 8204 sedighi_mostafa@yahoo.com Kermanshah University of Medical Sciences Iran (Islamic Republic of) Inclusion criteria: diagnosis of migraine according to ICHD III; written and informed consent of the patient or his guardian. Exclusion criteria: patients with abnormal imaging studies or EEG; a history of recent head trauma or drug abuse; having a secondary headache to infection (sinusitis, of otitis media, ...); and patients who coincident suffered from seizures and mood disorders ; being abnormal neurological examination 4 years 14 years Both G43 Migraine Treatment - Drugs In the experimental group, before starting the study the questionnaire of disability due to headache (PedMIDAS) will be provided, then levetiracetam tablets 20 mg per kg body weight), is prescribed and patients with a phone call and if its necessary by referring, every month follow up for at least 6 months and the questionnaire of disability due to headache (PedMIDAS) every 3 months untill 6 months, will be checked. And the frequency and severity of headaches will be checked in compare with before start of treatment Headache frequency. Timepoint: Beginning of the study, 1 ,3 and 6 months after study. Method of measurement: With the question of patient. The severity of migraine headaches. Timepoint: Beginning of the study, 1 ,3 and 6 months after study. Method of measurement: Based on questionnaire of determination of disability due to headache (PedMIDAS). Duration of headaches. Timepoint: Beginning of the study, 1 ,3 and 6 months after study. Method of measurement: With the question of patient. Vice chancellor for research, Kermanshah University of Medical Sciences Approved 2014-07-01 Ethics committee of Kermanshah University of Medical Sciences Building No.2, Shahid Beheshti, Vice Chancellor for Research Affairs, Kermanshah University of Medical Sciences Kermanshah Iran (Islamic Republic of)